Drug Development Solutions Ltd., Part of Alliance Pharma, Inc., Newmarket Road, Fordham, Cambridgeshire, CB7 5WW, UK.
Bioanalysis. 2023 Apr;15(7):391-405. doi: 10.4155/bio-2022-0236. Epub 2023 Apr 11.
The drive toward more sensitive LC-MS assays has resulted in long, complex methods. We assessed next-generation trypsins to identify a suitable candidate to integrate into protein LC-MS method development strategies, to simplify methods and increase throughput. The performance of commercially available next-generation trypsins was assessed based on the digestion of protein standards in buffer and complex matrix by LC-high-resolution MS. The performance of all next-generation trypsins assessed exceeded that of an overnight tryptic digest in a fraction of the time. Performing reduction and alkylation prior to digestion with heat-stable trypsins may be beneficial and should be investigated. Promega Rapid-Digestion Trypsin is the best-performing next-generation trypsin, surpassing an overnight tryptic digestion.
向更敏感的 LC-MS 分析方法的发展趋势导致了冗长、复杂的方法。我们评估了下一代胰蛋白酶,以确定合适的候选物,将其整合到蛋白质 LC-MS 方法开发策略中,以简化方法并提高通量。根据 LC-高分辨率 MS 在缓冲液和复杂基质中消化蛋白质标准品的情况,评估了市售下一代胰蛋白酶的性能。所有评估的下一代胰蛋白酶的性能都超过了在短时间内进行过夜胰蛋白酶消化的效果。在使用热稳定胰蛋白酶进行消化之前进行还原和烷基化可能是有益的,应该进行研究。Promega Rapid-Digestion Trypsin 是表现最好的下一代胰蛋白酶,超过了过夜胰蛋白酶消化。